Rici Healthcare Holdings Limited announced that Dr. Fang Yixin, an executive Director and the chairman of the Board, was appointed as the chief executive officer of the Company with effect from March 20, 2019. The Board announced that, with effect from March 20, 2019, (i) Mr. Lu Zhenyu has resigned as an executive Director and the Chief Executive Officer due to internal work responsibility adjustments, and has been appointed as the vice president of the Company, being responsible for Beijing branch of the medical examination business department of the Company and establishment and management of the Company's major customers department in Beijing, and (ii) Dr. Wang Weiping has resigned as an executive Director due to his age, and will continue to serve as a consultant to the Chief Executive Officer to provide his valuable advice on the Group's business and operation. The Board announced that with effect from March 20, 2019, Mr. Lu has ceased to be a member of the Remuneration Committee and Dr. Mei was appointed as a member of the Remuneration Committee, in replacement of Mr. Lu.